Healthcare Sector
Market Tracker
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 06/18/2026 | CALL | $50.00 | 1,834 | +26 | +1.44% |
| 09/18/2026 | PUT | $45.00 | 1 | +1 | |
| 06/18/2026 | CALL | $2.50 | 0 | 0 | |
| 06/18/2026 | CALL | $5.00 | 0 | 0 | |
| 06/18/2026 | CALL | $7.50 | 0 | 0 | |
| 06/18/2026 | CALL | $10.00 | 0 | 0 | |
| 12/17/2027 | PUT | $60.00 | 0 | 0 | |
| 12/17/2027 | PUT | $65.00 | 1 | 0 | |
| 06/18/2026 | PUT | $30.00 | 4,266 | -1 | -0.02% |
| 01/15/2027 | CALL | $45.00 | 9 | -5 | -35.71% |
| 06/18/2026 | CALL | $40.00 | 2,407 | -1,800 | -42.79% |
| 06/18/2026 | CALL | $45.00 | 3,224 | -1,804 | -35.88% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| Fidelity Advisor Biotechnology Fund | 3.08% | 807.71k | 14.39M |
| Vanguard Total Stock Market Index Fund | 0.31% | 81.69k | 1.46M |
| Vanguard Extended Market Index Fund | 0.09% | 23.87k | 425.42k |
| Fidelity Extended Market Index Fund | 0.07% | 18k | 320.83k |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 0.06% | 16.7k | 297.59k |
| iShares Micro Cap ETF | 0.04% | 9.29k | 165.53k |
| Fidelity Total Market Index Fund | 0.03% | 7.72k | 137.55k |
| Bridgeway Funds Inc-Ultra Small Company Fund | 0.03% | 6.97k | 124.29k |
| Fidelity Series Total Market Index Fund | 0.02% | 4.92k | 87.71k |
| Schwab Capital Trust-Total Stock Market Index Fund | 0.01% | 2.88k | 51.32k |
Enliven Posts Loss Beat and Cash Surge
08/13 06:15 pm
The Motley Fool
Read moreEnliven Therapeutics, Inc. Is a Great Choice for 'Trend' Investors, Here's Why
10/14 03:05 pm
Benzinga
Read moreEnliven Therapeutics Announces Positive Data Update from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia
09/28 09:35 am
GlobeNewswire Inc.
Read moreEnliven Therapeutics COO sells over $1.25m in company stock - Investing.com
07/16 06:44 pm
Investing.com
Read moreEnliven Therapeutics to Present at Two Upcoming Investor Conferences
05/29 04:05 pm
GlobeNewswire Inc.
Read moreEnliven Therapeutics Reports First Quarter Financial Results and Provides a Business Update
05/14 04:05 pm
GlobeNewswire Inc.
Read moreEnliven Therapeutics, Alpine Immune Sciences, Janux Therapeutics And Other Big Stocks Moving Higher On Thursday
04/11 10:01 am
Benzinga
Read moreEnliven Therapeutics Announces Positive Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 in Chronic Myeloid Leukemia
04/11 07:55 am
GlobeNewswire Inc.
Read moreEnliven Therapeutics Appoints Dr. Lori Kunkel to Board of Directors
04/09 04:05 pm
GlobeNewswire Inc.
Read moreEnliven Therapeutics Well-Positioned, With Conservative Trading Levels-Analyst Says
04/09 02:26 pm
Benzinga
Read moreNational CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday
03/19 10:03 am
Benzinga
Read moreEnliven Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
03/14 04:05 pm
GlobeNewswire Inc.
Read moreEnliven Therapeutics to Present at TD Cowen’s 44th Annual Health Care Conference
02/27 05:05 pm
GlobeNewswire Inc.
Read moreEnliven Therapeutics Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress
08/10 04:05 pm
GlobeNewswire Inc.
Read moreEnliven Therapeutics to Present at Two Upcoming Investor Conferences
05/31 04:55 pm
GlobeNewswire Inc.
Read more3 Stocks in the Limelight on New Analyst Coverage
04/11 07:01 am
Zacks Investment Research
Read moreBenzinga's Top Ratings Upgrades, Downgrades For March 29, 2023
03/29 11:00 am
Benzinga
Read moreBenzinga's Top Ratings Upgrades, Downgrades For March 3, 2023
03/03 11:00 am
Benzinga
Read more